The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - SERVIER
Research Funding - Celgene (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors.
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics
Research Funding - AstraZeneca; Puma Biotechnology
Travel, Accommodations, Expenses - AstraZeneca; Genentech; Puma Biotechnology
 
Ben Tran
Honoraria - Astellas Pharma; Janssen-Cilag; Sanofi; Tolmar
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Sanofi; Tolmar
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Genentech (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma
 
Jesus Corral Jaime
No Relationships to Disclose
 
Elena Garralda
No Relationships to Disclose
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - Boehringer Ingelheim; Merck Sharp & Dohme; Pfizer
Research Funding - Bayer; Janssen; Novartis; Sanofi
 
Jan H. M. Schellens
No Relationships to Disclose
 
Phillipe Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - Menarini; Novartis; SERVIER
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Philippe Cassier
No Relationships to Disclose
 
John Sarantopoulos
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis; Pfizer
 
Rashmi Chugh
Research Funding - AADi (Inst); Biomarin (Inst); Lilly (Inst); MabVax (Inst); Morphotek (Inst); Novartis (Inst)
 
Amit Mahipal
No Relationships to Disclose
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)
 
Cristiana Sessa
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Taiho Pharmaceutical (Inst)
 
Thomas Zander
Honoraria - Merck; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Novartis; Pfizer; Roche
 
Matthew Ng
Consulting or Advisory Role - ASLAN Pharmaceuticals; Baxalta; Lilly; MSD; Novartis
Research Funding - ASLAN Pharmaceuticals (Inst)
 
Giuseppe Curigliano
No Relationships to Disclose
 
Jennifer Bendiske
Employment - Novartis
 
Jose Manuel Perez-Garcia
No Relationships to Disclose